Understanding Macular Degeneration.

Age-related macular degeneration (AMD) is a progressive eye disease that damages the macula — the small, central area of the retina responsible for sharp, detailed vision. The macula is essential for tasks like reading, driving, and recognizing faces. As it deteriorates, central vision becomes blurred, distorted, or lost, while peripheral vision usually remains intact. AMD is the leading cause of irreversible vision loss in adults over 50 in the United States.

Dry AMD accounts for about 90% of cases and develops gradually as yellowish protein deposits called drusen accumulate beneath the retina, causing the macular tissue to thin over time. Wet AMD is less common (about 10%) but far more aggressive — it occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood, causing rapid and often sudden vision loss. Both forms affect central vision, but wet AMD requires urgent treatment with anti-VEGF injections to preserve sight.

The exact cause of AMD is not fully understood, but it results from a combination of aging, genetics, and environmental factors. As we age, the cells of the retinal pigment epithelium (RPE) that support the macula begin to break down, allowing waste products (drusen) to accumulate. Genetic variants — particularly in the CFH and ARMS2 genes — significantly increase susceptibility. Smoking, UV exposure, high blood pressure, high cholesterol, and obesity are all modifiable risk factors that accelerate the disease.

AMD is very common. It affects approximately 11 million Americans, making it the leading cause of vision loss in people over 50. By age 75, nearly one in three adults shows some sign of the disease. The prevalence is expected to increase as the population ages. While AMD is more common in Caucasians, it affects people of all races and ethnicities. Regular eye exams are critical for early detection, especially if you have a family history of the condition.

In its earliest stages, AMD often produces no symptoms at all — which is why regular dilated eye exams are so important. As the disease progresses, early signs may include subtle blurring of central vision, difficulty reading in low light, needing brighter lighting for close-up tasks, and colors appearing less vivid. These changes can be gradual and easy to dismiss, so any new visual changes in adults over 50 should prompt a comprehensive eye evaluation.

AMD is diagnosed through a comprehensive dilated eye exam. Your ophthalmologist will examine the retina for drusen deposits, pigment changes, or signs of abnormal blood vessel growth. Advanced diagnostic tools include optical coherence tomography (OCT), which creates detailed cross-sectional images of the retina, and fluorescein angiography, which uses a special dye to reveal leaking blood vessels in wet AMD. An Amsler grid test can also help detect distortion in central vision between office visits.

AMD affects central vision but does not cause total blindness. Your peripheral (side) vision is typically preserved, meaning you can still navigate your surroundings and perform many daily activities. However, the loss of central vision can make tasks like reading, driving, and recognizing faces very challenging. Early detection and prompt treatment — especially for wet AMD — are crucial for preserving as much central vision as possible and maintaining your quality of life.

AMD can affect one or both eyes, and it does not always progress at the same rate in each. Many patients are first diagnosed in one eye before the other becomes involved. When only one eye is affected, you may not notice symptoms because the healthy eye compensates. This is another reason comprehensive eye exams are essential — your doctor can detect changes in either eye that you might not feel or see on your own.

There is currently no cure for dry AMD, but its progression can be significantly slowed. For patients with intermediate to advanced dry AMD, AREDS2 nutritional supplements (containing vitamin C, vitamin E, zinc, copper, lutein, and zeaxanthin) have been clinically proven to reduce the risk of progression by approximately 25%. Lifestyle modifications — including a diet rich in leafy greens and omega-3 fatty acids, regular exercise, not smoking, and UV-protective sunglasses — also play an important role. Regular monitoring with OCT imaging allows your doctor to track changes and detect any conversion to wet AMD early.

Wet AMD is treated primarily with anti-VEGF injections — medications injected directly into the eye that block the growth of abnormal blood vessels and reduce fluid leakage beneath the retina. Commonly used anti-VEGF medications include ranibizumab (Lucentis), aflibercept (Eylea), and faricimab (Vabysmo). These injections are performed in-office, are relatively painless with topical anesthesia, and can stabilize or improve vision in the majority of patients when treatment begins promptly. Most patients require ongoing injections, initially monthly, with intervals gradually extended based on response.

Anti-VEGF stands for anti-vascular endothelial growth factor. VEGF is a protein your body produces that stimulates blood vessel growth. In wet AMD, excess VEGF causes abnormal, fragile blood vessels to form beneath the retina. Anti-VEGF medications block this protein, stopping new vessel growth and reducing leakage from existing vessels. The injection itself is quick, performed with a very fine needle after the eye is numbed with topical drops. Most patients describe it as feeling pressure rather than pain. Treatment typically begins with monthly injections, then the interval is adjusted based on how your eye responds.

Yes, for certain stages. The AREDS2 formula — containing vitamin C (500 mg), vitamin E (400 IU), zinc (80 mg), copper (2 mg), lutein (10 mg), and zeaxanthin (2 mg) — has been clinically proven to slow the progression of intermediate to advanced dry AMD by about 25%. However, these supplements are not beneficial for early-stage AMD or for people without the disease. They also do not treat wet AMD. You should only begin taking AREDS2 supplements under the guidance of your eye doctor, who can determine whether they are appropriate for your specific stage and risk profile.

While there is no guaranteed way to prevent AMD, you can significantly reduce your risk. Quitting smoking is the single most impactful step, as it doubles your risk. Eating a diet rich in leafy greens, colorful vegetables, and omega-3 fatty acids supports macular health. Regular exercise, maintaining healthy blood pressure and cholesterol levels, wearing UV-protective sunglasses outdoors, and scheduling comprehensive eye exams — especially after age 50 — are all proven strategies to lower your risk and catch the disease early when treatment is most effective.

Absolutely. Smoking is the single most significant modifiable risk factor for AMD. Smokers are two to four times more likely to develop macular degeneration than non-smokers. The toxins in cigarette smoke damage the delicate blood vessels in the retina, accelerate the formation of drusen deposits, and reduce protective antioxidant levels in the eye. The good news is that quitting smoking at any age reduces your risk. Former smokers eventually approach (though never fully reach) the risk level of people who have never smoked.

The American Academy of Ophthalmology recommends a baseline comprehensive eye exam at age 40 and regular dilated exams every one to two years after age 65. If you have risk factors for AMD — such as a family history, smoking history, or cardiovascular disease — you should begin regular screenings earlier and have them more frequently. If you ever notice sudden changes in your vision, such as straight lines appearing wavy or a dark spot in your central vision, seek an eye evaluation immediately, as these could indicate wet AMD requiring urgent treatment.